Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines
Open Access
- 1 September 1994
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (3) , 409-414
- https://doi.org/10.1038/bjc.1994.319
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesInternational Journal of Cancer, 1993
- Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursEuropean Journal Of Cancer, 1992
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitorGynecologic Oncology, 1992
- In vitro interactions between platinum analogues in human ovarian-carcinoma cell linesCancer Chemotherapy and Pharmacology, 1992
- Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trialEuropean Journal Of Cancer, 1992
- Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cellsGynecologic Oncology, 1990
- Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: Relationship to toxicityPharmacology & Therapeutics, 1987
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979